Role of Herbals in Decoding Complexities of Schizophrenic Brain, Neuroimaging and Genetic Biomarkers

Keywords

Abstract

References

1. [1]1. Anwar, A., Mustafa, A. M., Abdou, K., A. Rabie, M., El-Shiekh, R. A., & El-Dessouki, A. M. (2025). A comprehensive review on schizophrenia: epidemiology, pathogenesis, diagnosis, conventional treatments, and proposed natural compounds used for management. Naunyn-Schmiedeberg's Archives of Pharmacology, 1-25.
2. [2]2. Ashique, S., Pal, R., Islam, A., Sharma, H., Mandal, S., Kumar, S., ... & Pathak, R. (2025). Decoding the molecular mechanisms of miRNAs: protein interactions in schizophrenia pathogenesis. Current Protein & Peptide Science.
3. [3]3. Di Stefano, V., D’Angelo, M., Monaco, F., Vignapiano, A., Martiadis, V., Barone, E., ... & Steardo Jr, L. (2024). Decoding schizophrenia: How AI-enhanced fMRI unlocks new pathways for precision psychiatry. Brain Sciences, 14(12), 1196.
4. [4]4. Kraguljac, N. V., White, D. M., Reid, M. A., & Lahti, A. C. (2021). Neuroimaging biomarkers in schizophrenia. Frontiers in Psychiatry, 12, 665970. https://doi.org/10.3389/fpsyt.2021.665970
5. [5]5. Mamah, D. (2023). A review of potential neuroimaging biomarkers of schizophrenia risk. Journal of Psychiatry and Brain Science, 8(e230017), 1–12.
6. [6]6. Patil, S. T., Patil, S. S., & Patil, A. S. (2023). Neuroimaging and biomarker analysis in schizophrenia: Towards personalized treatment. Journal of Chemical Health Risks, 13(1), 45–55.
7. [7]7. Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C., Adkinson, B. D., & Anticevic, A. (2024). Neuroimaging biomarkers for drug discovery in schizophrenia. Biological Psychiatry, 95(3), 234–246. https://doi.org/10.1016/j.biopsych.2023.10.012
8. [8]8. Wei, X., Li, Y., & Zhao, H. (2023). A network-based machine learning approach using genetic biomarkers for schizophrenia classification. arXiv preprint arXiv:2302.00104.
9. [9]9. Wylie, K. P., Tregellas, J. R., & Tanabe, J. (2016). Targeting functional biomarkers in schizophrenia with neuroimaging. Neuropsychopharmacology Reviews, 41(5), 1186–1199.
10. [10]10. Yamada, T., Hashimoto, R. I., Yahata, N., Ichikawa, N., Yoshihara, Y., Okamoto, Y., & Kawato, M. (2017). Resting-state functional connectivity-based biomarkers and functional MRI-based neurofeedback for psychiatric disorders: A challenge for theranostic biomarkers. Neuroscience Research, 126, 43–52.
11. [11]11. Anwar, A., Khan, S., & Ahmad, S. (2025). A comprehensive review on schizophrenia: Epidemiology and herbal therapeutics. Naunyn-Schmiedeberg's Archives of Pharmacology. Advance online publication. https://doi.org/10.1007/s00210-025-04351-0
12. [12]12. Guo, J., He, C., Song, H., Gao, H., Yao, S., Dong, S. S., & Yang, T. L. (2024). Unveiling promising neuroimaging biomarkers for schizophrenia through clinical and genetic perspectives. Neuroscience Bulletin, 40(9), 1333-1352.
13. [13]13. Mujtaba, M. A., Gangane, P., Kaleem, M., Shahzad, N., Almutairy, A. F., Alshmmari, A. A. N., ... & Mahmood, D. (2025). Elucidating the Complex Etiology of Schizophrenia: Comprehensive Insights into the Therapeutic Roles of Natural Compounds and Pharmacological Interventions. Current Pharmaceutical Design.
14. [14]14. Yao, G., Zhang, Y., Liu, X., & Wang, J. (2025). Discovery of biological markers for schizophrenia based on metabolomics. Frontiers in Psychiatry, 16, 1540260. https://doi.org/10.3389/fpsyt.2025.1540260
15. [15]15. Zhao, J. N., Wang, Y. Q., Liu, M., Guo, B. B., Wang, Y. R., Gao, B., ... & Zhang, Y. L. (2025). Deciphering the molecular tapestry of schizophrenia: integrating transcriptomics, neuroimaging, and clinical data for precision medicine. Translational Psychiatry, 15(1), 489.

Authors (4)